Neurol. praxi. 2007;8(5):291-294

Psychiatrické symptomy Parkinsonovy nemoci: diagnostika a léčba

MUDr. Irena Rektorová, Ph.D.
Centrum pro abnormální pohyby a parkinsonismus, I. neurologická klinika LF MU, FN u sv. Anny, Brno

PN není onemocnění projevující se pouze hybnými příznaky – bradykinezí, tremorem, rigiditou a posturální instabilitou, ale na funkčním stavu a kvalitě života pacientů se výrazně podílejí především další nemotorické symptomy, jakož i pozdní hybné a psychické komplikace vlastní léčby. Následující článek je zaměřen na psychiatrickou problematiku PN.

Keywords: Parkinsonova nemoc, nemotorické symptomy, deprese, psychotická porucha, syndrom poruchy dopaminové regulace, demence

Published: December 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rektorová I. Psychiatrické symptomy Parkinsonovy nemoci: diagnostika a léčba. Neurol. praxi. 2007;8(5):291-294.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003; 60: 387-392. Go to original source... Go to PubMed...
    2. Burn DJ. Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease. Mov Disord 2002; 17: 445-454. Go to original source... Go to PubMed...
    3. Burn DJ, McKeith IG. Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease. Mov Disord 2003; 18(Suppl 6): 72-79. Go to original source... Go to PubMed...
    4. Dubois B, Pillon B. Cognitive deficits in Parkinson's diseasse. J Neurol 1997; 244: 2-8. Go to original source... Go to PubMed...
    5. Emre M, Aarsland D, Albanese A, Byrne EJ, Deuschl G et al. Rivastigmine for dementia associated with Patrkinson's disease. N Engl J Med 2004; 351: 2509-1518. Go to original source... Go to PubMed...
    6. Giovannoni G, O'Sullivan JD, Turner K, Manson AJ, Lees AJ. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 2000; 68: 423-428. Go to original source... Go to PubMed...
    7. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184. Go to original source... Go to PubMed...
    8. Lang AE, Widner H. Deep brain stimulation for Parkinson´s Disease: Patient Selection and Evaluation. Movement Disorders 2002; 17(Suppl. 3): 94-101. Go to original source... Go to PubMed...
    9. Lees AJ, Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain 1983; 106: 257-270. Go to original source... Go to PubMed...
    10. McKeith IG, Dickson DW, Lowe J et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005; 65: 1863-1872. Go to original source... Go to PubMed...
    11. Poewe W. Psychosis in Parkinson's disease. Mov Disord 2003; 18(Suppl. 16): 80-87. Go to original source... Go to PubMed...
    12. Rektorová I. Parkinson's Disease. Pharmacy and Therapeutics. In: Hospital Prescriber Europe. Mike Meakin, ed., Campden Publishing Ltd, London, UK 2001, p. 65-67.
    13. Rektorová I. Kognitivní a behaviorální poruchy u demence při Parkinsonově nemoci a u demence s Lewyho tělísky. Neurol pro praxi 2004; 1: 21-25.
    14. Rektorová I, Baláž M. Postup u psychotických komplikací Parkinsonovy nemoci. In: Rektor I et al. (ed.). Parkinsonova nemoc: doporučené postupy diagnostiky a léčby II. Pozdní stadium. Praha, Galen 2004, p. 23-25.
    15. Rektorová I, Rektor I, Bareš M, Dostál V, Ehler E, Fanfrdlová Z, Fiedelr J, Klajblová H, Kulišťák P, Ressner P, Svátová J, Urbánek K, Velísková J. Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study. Eur J Neurol 2003; 10: 399-406. Go to original source... Go to PubMed...
    16. Rektorová I, Rektor I. Parkinsonský syndrom. In: Rektor I, Rektorová I et al. Centrální poruchy hybnosti v praxi. Movement disorders. Praha, Triton 2003, p. 21-70.
    17. Rektorová I. Léčba deprese u Parkinsonovy nemoci. Boehringer Ingelheim, 2005.
    18. Rektorová I. Rivastigmin v léčbě demence u Parkinsonovy nemoci. Remedia 2006; 6: 609-613.
    19. Schrag A, Jahanshahi M, Quinn NP. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000; 69: 289-290. Go to original source... Go to PubMed...
    20. Wolters ECh, Francot CMJE. The Concept of mental dysfunctions in Parkinson's disease. In: Wolters ECh, Scheltens P and Berendse HW (eds): Mental Dysfunction in Parkinson's disease II. Academic Pharmaceutical Productions, 1999: 35-48.

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.